INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Aurora Cannabis Inc. - ACB

(MENAFN- GlobeNewsWire - Nasdaq) NEW YORK, July 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc. (“Aurora Cannabis” or the“Company”) (NASDAQ: ACB). Such investors are advised to contact Danielle Peyton at ... or 646-581-9980, ext. 7980.

The investigation concerns whether Aurora Cannabis and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here for information about joining the class action]

On June 18, 2025, Aurora Cannabis issued a press release reporting its financial results for the Company's fiscal fourth quarter and full year. Among other items, Aurora Cannabis advised investors to expect temporary declines in certain of its international markets in the current quarter, while warning that its adjusted EBITDA could decline as a result of lower revenue.

On this news, Aurora Cannabis's stock price fell $1.20 per share, or 20.41%, to close at $4.68 per share on June 18, 2025.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See .

Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Danielle Peyton
Pomerantz LLP
...
646-581-9980 ext. 7980

MENAFN06072025004107003653ID1109765621